A Randomized, Vehicle-Controlled, Double-Masked, Parallel-Group Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy
Latest Information Update: 23 Feb 2026
At a glance
- Drugs BL 1332 (Primary)
- Indications Ocular pain
- Focus Therapeutic Use
- Sponsors Bausch & Lomb
Most Recent Events
- 23 Feb 2026 New trial record